Definitive Healthcare DH Cash Flow Statement (2020-2026)

NASDAQ DH
$1.05 +0.01 (+0.96%)
At close: Sep 4, 2026 · 4:00 PM EDT
Reported Financials

Definitive Healthcare Quarterly Cash Flow Statement

Periods 26 quarters
Latest Jun 2026

Definitive Healthcare reported cash from operations of $11.46M and free cash flow of $9.07M for the quarter ended Jun 2026, up 23.1% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-21.37M-15.11M-13.04M-10.14M-6.88M5.89M-15.97M-11.61M-248.69M-13.36M-12.72M-306.19M-187.82M-84.72M-155.09M-9.27M-17.79M16.84M-192.35M-7.45M
Share-based CompensationStock Comp.
8.99M5.62M6.87M9.01M9.13M11.42M11.13M12.36M11.99M13.25M15.58M8.84M6.30M7.37M7.32M6.98M6.68M8.16M5.22M5.25M
Deferred Taxes
0.44M0.44M0.23M0.04M17.09M0.77M1.65M17.30M-1.01M0.85M21.99M13.77M6.06M11.01M-0.40M-0.30M0.57M3.54M0.47M
Asset Writedowns and ImpairmentWritedown
0.16M0.14M-0.14M1.22M0.21M0.70M0.42M-0.14M-0.18M-0.31M0.40M-0.21M0.02M
Cash from Restructuring
1.05M0.19M0.19M0.16M0.24M0.18M
Cash from OperationsCash from Ops.
-0.95M4.22M13.63M15.48M10.69M-4.22M14.96M12.04M9.49M4.71M16.59M14.04M19.43M8.13M26.07M9.30M15.69M2.72M11.56M11.46M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.47M0.18M0.18M0.17M0.18M0.17M0.18M0.17M0.18M0.17M0.18M0.17M0.18M0.17M0.13M0.12M0.13M0.14M0.16M0.18M
Depreciation & Amortization (CF)Dep. & Amort.
0.45M0.56M0.53M0.73M0.47M0.47M0.51M0.45M0.43M0.56M0.55M0.60M0.56M0.53M0.59M0.87M0.85M0.99M1.00M1.07M
Change in Working Capital
Change in ReceivablesChange Receivables
5.30M15.90M-8.53M-6.74M2.82M25.68M-6.97M-6.92M-5.49M18.56M-3.00M-12.20M-7.95M17.45M-10.35M-5.52M-3.48M17.97M-13.26M-7.96M
Change in Accured ExpensesChange Accured Exp.
-1.85M7.39M-3.00M2.00M6.83M-2.69M-3.85M0.83M1.43M2.92M-8.23M-2.06M5.12M-0.28M-8.74M-3.40M12.50M-1.44M-11.57M-1.96M
Investing Activities
Capital ExpendituresCapex
0.44M1.21M3.50M1.00M3.82M1.34M0.74M0.30M0.59M0.27M0.82M0.35M10.90M7.71M2.29M2.28M4.44M3.76M2.39M
Acquisitions
40.00M56.50M-0.20M45.02M13.53M
Cash from Investing ActivitiesCash from Investing
-0.44M-41.07M-166.85M-10.18M-3.98M-67.89M-33.47M1.34M-54.06M54.41M-24.03M14.93M8.96M-26.27M83.55M-10.16M24.14M56.35M-6.22M4.90M
Financing Activities
Cash from Financing ActivitiesCash from Financing
152.76M234.68M-4.38M-6.75M-6.12M-9.46M-3.52M-5.63M-10.37M-6.06M-17.19M-14.12M-12.06M-13.37M-109.71M-24.70M-12.47M-3.91M-10.88M-3.02M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
0.07M0.03M0.06M0.24M0.54M2.08M2.55M
Net Equity Issued and RepurchasedNet Equity Issued
382.14M
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common)
3.81M0.99M0.26M5.03M1.65M5.93M2.83M7.87M1.59M0.10M2.32M0.32M
Additional items
Exchange Rate EffectFX Effect
-0.06M-0.08M-0.11M-0.14M0.04M-0.33M0.07M-0.32M0.01M0.46M-0.34M0.06M0.38M-0.73M0.82M0.44M-0.02M0.15M-0.45M-0.12M
Change in Cash
151.37M197.83M-157.59M-1.45M0.59M-81.56M-22.04M7.75M-54.94M53.05M-24.64M14.85M16.33M-31.50M-0.10M-25.56M27.36M55.16M-5.53M13.34M
Free Cash FlowFCF
-1.39M3.01M10.13M15.48M9.68M-8.04M13.62M11.30M9.18M4.12M16.32M13.21M19.08M-2.77M18.36M7.01M13.41M-1.72M7.81M9.07M
Net Cash FlowNCF
151.37M197.83M-157.59M-1.45M0.59M-81.56M-22.04M7.75M-54.94M53.05M-24.64M14.85M16.33M-31.50M-0.10M-25.56M27.36M55.16M-5.53M13.34M